Top Markets
Coin of the day
Rebus Holdings, Inc. Rebus Holdings, Inc.

Rebus Holdings, Inc.

RBSH
Rangering i aksjer #42217
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for... Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was established in 2003 and maintains its headquarters in Westlake Village, California.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$3.21K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Rebus Holdings, Inc. (RBSH)

Kategori

Aksjeprishistorikk for Rebus Holdings, Inc. (RBSH)
Høyeste sluttskurs: $0.00 den 2026-08-01

Laveste sluttskurs: $4.22M den 2009-11-01
Aksjeprishistorikk for Rebus Holdings, Inc. fra 2009 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 0.00%
2025 -4.55%
2024 -98.16%
2023 -39.81%
2022 -78.02%
2021 -92.91%
2020 -96.74%
2019 -93.08%
2018 -87.91%
2017 -96.90%
2016 -82.98%
2015 -64.73%
2014 -46.26%
2013 -46.40%
2012 18.83%
2011 1.07%
2010 -3.78%
2009 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.57%
KR